NCT05597605View on ClinicalTrials.gov

The SHINE Study: Safety of Implant and Preliminary Performance of the SHINE SYSTEM in Diabetic Subjects

NACompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

September 21, 2022

Primary Completion Date

December 19, 2023

Study Completion Date

January 23, 2024

Conditions
Diabetes MellitusDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2Ketoacidosis, DiabeticHyperglycaemia (Diabetic)Hypoglycemia
Interventions
DEVICE

The SHINE SYSTEM

The FUSHO sensor, which is part of the SHINE SYSTEM, is a continuous multi-metabolite monitoring (CMM) sensor which is a miniaturized near-infrared spectrometer that measures the absorption of light in the interstitial fluid to quantify the concentration of multiple metabolites

Trial Locations (3)

2650

University Hospital Àntwerp, Antwerp

Unknown

Lapeyronie Montpellier University Hospital, Montpellier

University Medical Centre, Ljubljana

All Listed Sponsors
lead

Indigo Diabetes NV

INDUSTRY